The prevalence of early-stage lung adenocarcinoma (LUAD) has increased alongside
increased implementation of lung cancer screenings. Robust discrimination criteria are …

Gastric cancer (GC) is one of the most fatal cancers in the world. Thousands of biomarkers
have been explored that might be related to survival and prognosis via database mining …

Background Endometrial cancer (EC) is one of the three major gynecological malignancies.
Numerous biomarkers that may be associated with survival and prognosis have been …

The tumor suppressor p53, encoded by the TP53 gene, is mutated or nullified in nearly 50%
of human cancers. It has long been debated whether TP53 mutations can be utilized as a …

Background The objective of this study was to evaluate patterns, predictors, and long-term
outcomes of recurrent disease after complete resection for early-stage non-small cell lung …

Background Intra-tumor heterogeneity stems from genetic, epigenetic, functional, and
environmental differences among tumor cells. A major source of genetic heterogeneity …

We identified and investigated the prognostic value of secreted phosphoprotein 1 (SPP1) in
lung adenocarcinoma (LUAD) patients and evaluate the relationship between the SPP1 …

Neoadjuvant chemotherapy is the current standard of care for large, advanced, and/or
inoperable tumors, including triple‐negative breast cancer. Although the clinical benefits of …

Current prognostic signatures need to be improved in identifying high‐risk patients of gastric
cancer (GC). Thus, we aimed to develop a reliable prognostic signature that could assess …

Simple Summary We treat prostate cancer like it is one disease, but it is clear that it behaves
like different diseases in different patients, with some having excellent responses to …